In addition, variability in GLUT2, also involved in insulin secretion, and in the glucose transporter SGLT2, resulted in altered CV event-free survival, which is particularly relevant in a pathology such as DN, which confers an exceptionally high CV risk. This evidence concerns the gene INS and liver dysplastic nodule.